Fosun Pharma updates board, committee appointments

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. now operates with a 12-member board of directors, which includes executive, non-executive, independent non-executive, and employee directors. Mr. Chen Yuqing serves as chairman, Ms. Guan Xiaohui as co-chairman, and Mr. Wen Deyong as vice chairman among the executive directors. The board also includes five specialized committees: Strategic, Audit, Nomination, Remuneration and Appraisal, and Environmental, Social and Governance (ESG).

Key appointments to these committees highlight leadership roles. Mr. Chen Yuqing chairs the Strategic Committee and is a member of the ESG Committee. Ms. Guan Xiaohui is a member of both the Nomination and ESG Committees. Independent non-executive directors also hold significant positions; Mr. Yu Tze Shan Hailson is a member of the Nomination and Remuneration and Appraisal Committees and chairs the ESG Committee, while Mr. Wang Quandi is a member of the Audit and ESG Committees and chairs the Nomination Committee. Mr. Chen Penghui is a member of the Strategic, Nomination, and Remuneration and Appraisal Committees. Mr. Yang Yucheng chairs the Audit Committee and is a member of the Remuneration and Appraisal and ESG Committees.

The board structure ensures comprehensive oversight across various aspects of the company's operations, reflecting governance and strategic direction. The employee director, Ms. Yan Jia, does not appear to hold committee memberships. This update was announced on December 2, 2025.